Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience

被引:15
作者
Borhani-Haghighi, Afshin [1 ,2 ]
Haza, Shahab Ghasem [3 ]
机构
[1] Shiraz Univ Med Sci, Sch Med, Dept Neurol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Transgen Technol Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Res Ctr Tradit Med & Hist Med, Shiraz, Iran
关键词
Classification; neurological; systemic lupus erythematosus; CENTRAL-NERVOUS-SYSTEM; PART; PREVALENCE; HEADACHE;
D O I
10.4103/0972-2327.64633
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: To evaluate the prevalence and characteristics of different neurological and psychiatric presentations in patients admitted to hospital with systemic lupus erythematosus (SLE). Materials and Methods: In this retrospective hospital-based study, we examined the medical records of patients with SLE who were referred to the hospitals affiliated to Shiraz University of Medical Sciences from 1995 to 2005. All patients of SLE who had clinical neurological or psychiatric features were included in this study. The patients' demographic data, findings on general examination, neuropsychiatric manifestations, and the results of laboratory investigations and imaging studies were recorded. Clinical manifestations were classified according to the American College of Rheumatology (ACR) case definitions. Results: Of the 407 study patients, 11.3% had neuropsychiatric complications. The most frequent findings were seizure (63%), headache (60%), and decreased level of consciousness (50%). Cerebrovascular disease (28.3%), seizure disorder (26.5%), and acute confusional state (19.6%) were the most prevalent syndromes. Conclusion: The prevalence and nature of different neurological presentations of SLE in Iranian patients has some similarities to that seen in other populations, as well as some differences. Ethnic and environmental factors may contribute to these differences.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 33 条
[1]   Neuropsychiatric lupus syndromes -: Relationship with antiphospholipid antibodies [J].
Afeltra, A ;
Garzia, P ;
Mitterhofer, AP ;
Vadacca, M ;
Galluzzo, S ;
Del Porto, F ;
Finamore, L ;
Pascucci, S ;
Gasparini, M ;
Laganà, B ;
Caccavo, D ;
Ferri, GM ;
Amoroso, A ;
Francia, A .
NEUROLOGY, 2003, 61 (01) :108-110
[2]   The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus [J].
Ainiala, H ;
Loukkola, J ;
Peltola, J ;
Korpela, M ;
Hietaharju, A .
NEUROLOGY, 2001, 57 (03) :496-500
[3]   Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? [J].
Baker, JF ;
Krishnan, E ;
Chen, L ;
Schumacher, HR .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :816-826
[4]   Neuropsychiatric syndromes in lupus -: Prevalence using standarized definitions [J].
Brey, RL ;
Holliday, SI ;
Saklad, AR ;
Navarrete, MG ;
Hermosillo-Romo, D ;
Stallworth, CL ;
Valdez, CR ;
Escalante, A ;
del Rincón, I ;
Gronseth, G ;
Rhine, CB ;
Padilla, P ;
McGlasson, D .
NEUROLOGY, 2002, 58 (08) :1214-1220
[5]  
BRINCIOTTI M, 1993, LUPUS, V2, P281
[6]   CHOREA AND SYSTEMIC LUPUS-ERYTHEMATOSUS - A CRITICAL-REVIEW [J].
BRUYN, GW ;
PADBERG, G .
EUROPEAN NEUROLOGY, 1984, 23 (04) :278-290
[7]   Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) [J].
Cimaz, R ;
Meroni, PL ;
Shoenfeld, Y .
LUPUS, 2006, 15 (04) :191-197
[8]  
COSTALLAT LTL, 2001, ARTHRITIS RHEUM, V44
[9]   Cognitive dysfunction in systemic lupus erythematosus [J].
Emori, A ;
Matsushima, E ;
Aihara, O ;
Ohta, K ;
Koike, R ;
Miyasaka, N ;
Kato, M .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (05) :584-589
[10]   FREQUENCY, ETIOLOGY, AND PREVENTION OF STROKE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FUTRELL, N ;
MILLIKAN, C .
STROKE, 1989, 20 (05) :583-591